GlaxoSmithKline (GSK) implemented Aspen Mtell® to increase the robustness of their pharma supply chains by preventing unplanned production downtime.
With Aspen Mtell, GSK saw the following results:
- 35 days’ advance warning of potential issues
- Tens of millions of USD in lost batches avoided
- 50% reduction in lifecycle maintenance costs
- 30 sites across 18 countries covered, multiplying value gained
Learn more about how AspenTech’s technology empowers GSK to create a reliable, future-ready supply chain.